These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16339517)

  • 1. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
    Verneris MR; Karimi M; Baker J; Jayaswal A; Negrin RS
    Blood; 2004 Apr; 103(8):3065-72. PubMed ID: 15070686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
    J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2D splice variants: a reexamination of adaptor molecule associations.
    Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
    Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
    Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
    J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
    Fikri Y; Nyabenda J; Content J; Huygen K
    Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
    Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
    J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.
    Chen X; Bai F; Sokol L; Zhou J; Ren A; Painter JS; Liu J; Sallman DA; Chen YA; Yoder JA; Djeu JY; Loughran TP; Epling-Burnette PK; Wei S
    Blood; 2009 Apr; 113(14):3226-34. PubMed ID: 19075187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
    Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
    Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.
    Coudert JD; Scarpellino L; Gros F; Vivier E; Held W
    Blood; 2008 Apr; 111(7):3571-8. PubMed ID: 18198346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An activating immunoreceptor complex formed by NKG2D and DAP10.
    Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
    Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
    Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
    J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.
    Wu J; Cherwinski H; Spies T; Phillips JH; Lanier LL
    J Exp Med; 2000 Oct; 192(7):1059-68. PubMed ID: 11015446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.
    Marusina AI; Burgess SJ; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2008 Jan; 180(1):409-17. PubMed ID: 18097042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sestrins induce natural killer function in senescent-like CD8
    Pereira BI; De Maeyer RPH; Covre LP; Nehar-Belaid D; Lanna A; Ward S; Marches R; Chambers ES; Gomes DCO; Riddell NE; Maini MK; Teixeira VH; Janes SM; Gilroy DW; Larbi A; Mabbott NA; Ucar D; Kuchel GA; Henson SM; Strid J; Lee JH; Banchereau J; Akbar AN
    Nat Immunol; 2020 Jun; 21(6):684-694. PubMed ID: 32231301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.